Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho

Clin Mol Hepatol. 2025;31(1):32-55. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0734

View: 1734 Download: 222 Web of Science: 1 Crossref: 1

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 13377 Download: 250 Web of Science: 79 Crossref: 85

Yeon Seok Seo, Vijay H. Shah

Clin Mol Hepatol. 2012;18(4):337-346. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.337

View: 13104 Download: 208 Crossref: 84

Kyu Won Chung

Clin Mol Hepatol. 2002;8(4):505-514. Published online January 1, 1970

View: 2702 Download: 12

Jin Mo Yang

Clin Mol Hepatol. 2001;7(2):216-219. Published online January 1, 2000

View: 2158 Download: 15

1 |

Viewed By 6971	MAFLD: How is it different from NAFLD?
Viewed By 6219	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5315	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5147	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4664	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 170	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search